Revolutionary diagnostic cancer test - VIB
Frontiers | Is There a Place for Immunotherapy for Metastatic Microsatellite Stable Colorectal Cancer? | Immunology
Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trials - European Journal of Cancer
Immunotherapy in the treatment of colorectal cancer: a new kid on the block
Colorectal Cancer
Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms | British Journal of Cancer
Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis | British Journal of Cancer
References in International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study - The Lancet
VIB - Biocartis ontvangt subsidie voor ontwikkeling van volledig geautomatiseerde MSI test
Cells | Free Full-Text | Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study | HTML
Checkpoint Inhibition: A Promising Immunotherapeutic Approach for Colorectal Cancer | Personalized Medicine in Oncology
Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial† - Annals of Oncology
Clinical Performance of the Idylla MSI Test for a Rapid Assessment of the DNA Microsatellite Status in Human Colorectal Cancer - The Journal of Molecular Diagnostics
Frontiers | Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies | Immunology
References in Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study - The Lancet Oncology
Subtyping of microsatellite instability-high colorectal cancer | Cell Communication and Signaling | Full Text
Stomach and colorectal cancer: AI identifyies patients for immunotherapy • healthcare-in-europe.com
MSI/MSS Colorectal Cancers - TRanslational ONCOlogy
Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer | Scientific Reports
PDF) The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer | NEJM
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability: Immunity
